Updated Jul 16, 2026
Scadden David has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $89K.

David Scadden is a director at Agios Pharmaceuticals, Inc., a biopharmaceutical company specializing in cellular metabolism and treatments for rare diseases. He has been involved in multiple SEC filings related to his role at the company.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2025-10-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale | 200 | $41.00 | $8K |
| 2025-10-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 200 | $18.09 | $4K |
| 2025-09-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale | 200 | $40.00 | $8K |
| 2025-09-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 200 | $18.09 | $4K |
| 2025-08-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale | 200 | $40.00 | $8K |
| 2025-08-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 200 | $18.09 | $4K |
| 2025-07-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale | 1.4K | $40.00 | $56K |
| 2025-07-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 1.4K | $18.09 | $25K |
| 2024-12-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 200 | $46.28 | $9K |
| 2024-12-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 200 | $18.09 | $4K |
David Scadden is a director at Agios Pharmaceuticals, Inc., a biopharmaceutical company specializing in cellular metabolism and treatments for rare diseases. He has been involved in multiple SEC filings related to his role at the company.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($89K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Scadden David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.